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Abstract
Aim—To improve evidence for public health practice, the conduct of effectiveness studies by 
practitioners is needed and may be stimulated if knowledge that smaller than usual samples may 
provide the same reliability of intervention effect size as larger samples.
Materials & methods—We examined reliability of intervention effect using computerized 
simulations of 2000 hypothetical immunization effectiveness studies from an actual study 
population and by small (30 and 60) and larger (100 and 200) control groups compared with an 
intervention group of 200 participants.
Results & conclusion—Across simulated studies, the mean intervention effect (14%) and 
effect sizes were equivalent regardless of control group size and equal to the actual study effect. 
These results are relevant for similarly designed and executed studies and indicate that studies with 
smaller control groups can generate valid and accurate evidence for effective public health practice 
in communities.
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Background
Widespread interest in comprehensive, scientific evidence for public health practice in the 
USA that examines community studies for intervention effectiveness is relatively new and 
earnestly took hold in 1996 with formation of the Community Preventive Services Task 
Force (CPSTF) and subsequent publication of the Guide to Community Prevention Services 
(Community Guide) [1–5]. With enactment of the Patient Protection and Affordable Care 
Act in 2010, the CPSTF has taken on a legislated role [6]. Under the provision to prevent 
chronic disease and improve health, the CPSTF is to provide recommendations from the 
scientific review of effectiveness, appropriateness and cost–effectiveness of community 
preventive interventions such as policies, programs, processes or activities designed to affect 
health at the population level.
The Community Guide provides a broad array of recommendations for communities. 
Recommendations include health topics addressing population-level behaviors, diseases, 
injuries and social factors imposing the greatest health burden and offering the broadest 
range of health promotion and disease prevention interventions for communities. These 
recommendations draw on the most current comprehensive assessment of scientific evidence 
from systematic reviews of population-based effectiveness studies [1,2,7]. Such 
effectiveness studies typically are conducted in the USA after efficacy studies demonstrate 
an intervention works under ideal conditions [8]. These effectiveness studies are designed 
specifically to answer the question of whether an intervention works under real world 
conditions [8]; and therefore, identify interventions likely to lead to effective and efficient 
public health programs implemented in the community or at the local level.
The group- or cluster-randomized controlled community trial is a common epidemiologic 
study for assessing community or population-level effectiveness [1,9–11]. Main advantages 
of this study design are similar to the randomized controlled trial (RCT) for examining 
efficacy of clinical practice [9]. Instead of double-blind randomized assignment of 
individuals to control and treatment groups as in the RCT, in the group-RCT random 
assignment is of a population at a group or cluster level, while the unit of observation is 
usually at the individual level [9]. The group or cluster RCT is among the best designs for 
providing evidence for population-level effectiveness, because it has some advantages of an 
RCT, providing high levels of internal validity [11]. The group randomized trial also 
overcomes any impracticality of double blinded randomization of individuals in a 
population- level effectiveness study. As with the RCT, cost is one major drawback to a large 
group controlled trial. A large study may be difficult for local public health agencies and 
communities to conduct because of limited resource availability and competing service 
priorities for available resources.
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In fact, a survey of key public health informants of epidemiologists practicing for more than 
20 years in local and state public health agencies identified financial constraints in making 
comprehensive, evidence-based decisions in public health at the community level because of 
the perceived need for large studies [12]. Difficult questions may not be addressed or 
subpopulations may not be evaluated in effectiveness studies because of the concern about 
the cost of large studies. In a recent review of effectiveness studies published as background 
articles for recommendations of the Community Guide, many effectiveness studies did not 
include a control group nor are they able to infer to certain racial and ethnic minority 
subpopulations because of insufficient sample size [1,7,11]. Ideally, relatively inexpensive, 
valid and reliable methods are likely of value in improving the evidence base for public 
health practice and community health.
To improve the amount and quality of available evidence for public health practice and 
practice-based evidence, an unbalanced design, using a relatively small sample size for a 
control group with a larger intervention group could be considered. In contrast to studies 
with no control group, inclusion of a control group improves the internal validity or 
attribution of intervention effect. As a comparison group, the control group typically 
implements the standard of care and is not exposed to the intervention but has characteristics 
similar to those of the intervention group that predict outcome [9,13].
For many researchers, a small control group seems counterintuitive. First, a small sample 
may lack the precision for providing reliable answers to the question under investigation. In 
addition, an unbalanced design with a small sample size may not allow for sufficient 
statistical power to detect a difference between intervention and control groups (i.e., low 
power) [13]. A fundamental concern is that group-level assignment of control and 
intervention groups also adds another level of variation (intergroup variance) to consider in 
analyzing results to account for any intragroup or intra-class correlation among members in 
the same group [9]. A critical review seems warranted of when and under what 
circumstances a small control group can be used in group-randomized, effectiveness studies. 
To answer the question does a small control group size provides valid results, this paper 
addresses the question using a different approach to describe the reliability in estimating an 
intervention effect from an effectiveness study (group randomized trial) with a small control 
group compared with larger control groups. The approach of computerized simulations is 
more understandable to a broader audience of practitioners. Our objective is to examine 
whether a small control group yields equivalent size of intervention effects, defined as the 
simple difference between two proportions [14].
Materials & methods
Study design
Computerized simulations of hypothetical effectiveness studies were performed to examine 
equivalence of intervention effects. As an example, simulations were performed with data 
from an actual effectiveness study of an immunization intervention. The study was 
conducted in early 1990s by the first author and colleagues. This actual effectiveness study 
was a group-randomized controlled intervention trial reviewed and rated by the CPSTF as 
having greatest suitability for assessing effectiveness of immunization interventions [15,16]. 
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The actual effectiveness study included large intervention and control groups (approximately 
14,000 children combined).
Actual study population
Study population, design & intervention effectiveness measurements—In the 
actual study population, change in vaccination levels or coverage among children 13–35 
months of age in seven of 48 sites for the Special Supplemental Nutrition Program for 
Women, Infants and Children (WIC) in Chicago from 1990–1992 was compared between 
intervention and control groups [16]. Two WIC sites were randomly assigned to a control 
group and five sites were randomly assigned to three different types of intervention groups 
with an overall three-part intervention of vaccine assessment, vaccine referral and a voucher 
incentive (e.g., two sites to one intervention, two sites to second intervention and one site to 
third intervention). Group assignment was chosen because randomization of individuals in a 
WIC site was not operationally practical as an intervention. Methods for assessment of 
vaccination status and implementation of a voucher incentive were the same at all 
intervention sites; intervention groups only varied by referral to a healthcare provider for 
immunization either on site in the WIC clinic, down the hall to a pediatric clinic or off site to 
a provider in the community [16]. The voucher incentive for all interventions included 
issuing a 3-month supply of food vouchers if vaccinations were up to date instead of a 1-
month supply.
The intervention effect was defined as the difference in changes from baseline vaccination 
coverage (percentage of up-to-date children for vaccination) after the intervention was 
introduced at a WIC site between intervention and control groups. Vaccination coverage was 
measured by conducting cross-sectional surveys of 13- to 35-month-old children in a site 
before the intervention and 1 and 2 years after the intervention began. For the purposes of 
simulating hypothetical studies, the change from the baseline percentage of up-to-date 
children for vaccination was only 1 year after the intervention began, and this change in 
coverage in control sites was subtracted from the change in baseline coverage in the 
intervention sites (Table 1). For the purpose of generating samples of control and 
intervention populations in simulated studies, all children in control sites were combined 
into one control group and all intervention sites were combined into one intervention group. 
The arithmetic difference between control and intervention groups was chosen as the method 
for estimating intervention effect from simulated studies [14]. Of five intervention sites, 
approximately 1000 children were in each of the baseline and follow-up surveys and nearly 
400 or more were in these surveys for the two control sites combined. Observed intervention 
effect in the actual study was 14.4% (95% CI: 13.5–15.2%).
Surveyed children in study sites had similar demographic characteristics, extent of WIC 
participation and receipt of other federal assistance at baseline as those in seven study sites 
and all 48 WIC sites in Chicago. Because these characteristics were known to affect 
vaccination status of children, the survey sample of children was considered representative 
of all WIC enrolled children in Chicago [16].
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Assessment of intragroup correlation—Intraclass correlation (ICC) was assessed for 
baseline vaccination coverage by intervention and control groups in the actual study to 
determine if the ICC was significant and should be included in estimating uncertainty of the 
intervention effect. Using standard computations for ICC [9], approximately 3% of the total 
variance in the difference in vaccination coverage between the control and intervention 
groups at baseline was due to correlation among individuals within the same group (control 
or intervention groups). Because the ICC was very small, it was excluded from simulated 
studies.
Simulations—Computerized simulations generated hypothetical studies from the actual 
study population and provided distributions of intervention effects by control group size. 
From these distributions, intervention effects were examined by precision of mean effects, 
statistical power and mean square error (MSE). Precision, or the width of the 95% CI, was 
computed as an epidemiological measure of uncertainty, describing the magnitude of 
random error in estimating a population parameter from a sample [14,17]. Because the 
intervention effect was a difference between proportions, precision was computed by 
subtracting the lower 95% confidence limit from the upper confidence limit [14,17]. 
Statistical power was chosen as another measure, because it is a fundamental consideration 
in estimating sample size requirements for a study. Although power is not a direct measure 
of the degree of uncertainty, power is a critical element in sample size requirements and 
measures the probability that a study detects a statistically significant difference under the 
null hypothesis if there is a true difference in the population [14]. MSE was chosen because 
it represents an index of uncertainty. As a measure of uncertainty that captures both random 
error and systematic bias, it is an average closeness of an estimator to the population 
parameter and equals the mean of squared deviations of the observed estimate from the true 
parameter [18]. The true parameter was the intervention effect of 14%, previously mentioned 
from the actual study, and the mean squared deviations of the observed effects from 
simulated studies were each subtracted from the actual study effect of 14% for computing 
the MSE.
In simulated studies, sample sizes as small as 30 and as large as 200 were examined for the 
control group. A sample size as small as 30 was chosen because this size is considered large 
enough to assume that variability of an intervention estimate can be closely approximated by 
a normal distribution from the central limit theorem [19]. The intervention group included 
only a large sample size of 200 participants. To select different sizes of a control group, a 
bootstrap method of random sampling with replacement was performed. The bootstrap 
macro is a commonly used and well-established macro named Jackboot. It has been updated 
over the years and we used the latest published version at the time of this study [20,21]. In 
our study we used the macro to produce estimates with the bias-corrected accelerated 
methods to produce CIs and to observe both plots and statistics to check if the distribution 
was approximate normal. These bias-corrected accelerated methods allowed us to correct, if 
needed, the percentile interval for bias and skewness. To display simulations by control 
group size, for convenience Minitab 13 software was used because a figure and descriptive 
statistics could be shown side by side.
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When the sample size for both the control and intervention groups were 200 participants, the 
design was considered balanced; otherwise, it was considered an unbalanced design. For 
each sample size (30, 60, 100 and 200) of the control group, 2000 simulated studies were 
created; this number was adequate for computing an approximate or asymptotic 95% CI for 
the mean intervention effect. To obtain the intervention effect for each of the 2000 simulated 
studies, the bootstrap macro also enabled analysis of the randomly selected children from 
each of the four cross-sectional surveys (two surveys each (baseline and 1-year follow-up) 
for the control group and intervention group) [20–22]. Percentage of children aged 13–35 
months who were up to date for vaccination was computed from each sample in each of the 
four surveys.
Statistical analysis—An empirical distribution and asymptotic statistical methods 
described the intervention effect from the 2000 simulated studies by control group size and 
reliability of estimation. Asymptotic methods were chosen, because they are most 
commonly applied in statistical practice [19]. Frequency distribution of estimated 
intervention effects were, in general, normally distributed [19] and descriptive statistics were 
computed in MINITAB 13 software for convenience as previously mentioned [23]. Precision 
of mean intervention effect for simulated studies for each sample size of the control group 
was derived from the 95% CI in MINITAB (uncorrected for bias). The mean intervention 
effect was chosen because it was the most common estimate. In MINITAB, the 95% CI was 
computed by multiplying the approximate standard error by 1.96 [24]. For convenience, 
mean power was computed by control group size in SAS version 9.3 [25]. A two-sided Type 
I error (α) of 0.05 was used to estimate power from a study measuring the difference of two 
means. Although the first difference computed in the actual study at baseline was of two 
proportions, the second difference (difference of the 1-year changes from baseline 
vaccination coverage between control and intervention groups) was of two mean 
proportions, which could have values between -1 to 1. Power was one minus the probability 
of a Type II error (β), which was derived from a one-sided Z value. From simulated studies 
by control group size, squared errors from the intervention effect in the actual study were 
computed as the MSE.
Results
Simulations
Intervention effect—Mean intervention effect for the simulated studies with 200 children 
in the intervention group and different sample sizes of children in the control group was the 
same as the observed estimate of 14% in the actual study, regardless of size of control group 
(Figures 1–4). For instance, 14% was the mean intervention effect from simulated studies 
with a control group of 30 participants, which was the same for studies with larger control 
groups. Although the empirical distribution of intervention effects by study design showed 
that most simulated studies found an elevated intervention effect, the percentage of 
simulated studies with an elevated effect increased as control group size increased (30 
participants: 85%; 60 participants: 92%; 100 participants: 96%; and 200 participants: 99%).
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Measures of uncertainty—Precision of mean intervention effect varied by sample size 
of the control group (Figure 5A). Imprecision was largest (±1.2%) for the study design with 
a control group of 30 participants and decreased for designs with increasing size of control 
group. Imprecision was lowest (±0.6%) for the design with a control group of 200, which 
was one half precision of the design with a small control group. In general, estimated mean 
intervention effects for simulated studies by control group size based on precision of 
estimated effect was equivalent regardless of sample size of control group.
Average power in detecting a true difference was high regardless of control group sizes, 
because the actual intervention effect was a relatively large difference (14%) (Figure 5B). 
With a two-sided Type I error of 0.05, the mean power for studies with a control size of 30 
was approximately 99%. Power was the same for studies with larger sample sizes for control 
groups.
MSE slightly varied by size of control group. Because study bias was minimal, MSE 
approximated variance of distribution of intervention effects by size of the control group. 
The MSE was 1.7 × 10−2 for a small control group of 30 participants, and was lower for 
larger control groups (60 participants: 0.9 × 10−2; 100 participants: 0.8 × 10−2; and 200 
participants: 0.7 × 10−2).
Discussion
In thousands of stimulated studies with control groups of 30, 60, 100 or 200 participants 
compared with an intervention group of 200 participants the average intervention effect was 
the same as the effect in the actual study population regardless of sample size of the control 
group. The empirical distribution suggests that, on average, the mean intervention effect 
(14%) from stimulated studies would have been the same as the effect in the actual study 
population if the group-RCT had a control group as small as 30 participants. Our close 
results, regardless of control group size, may be explained by a well-designed and executed 
actual study with a representative population of all children enrolled in WIC [16]. It is well 
known in sampling theory that truly random samples (i.e., not affected by selection bias) 
result in unbiased estimates of true effects. Since we have randomly sampled from a dataset, 
it is expected that, regardless of sample size, we should find on average the same effect 
estimates as the actual study data. Despite this fact from sampling theory, most practitioners 
still think that very large controls are needed and do not understand or make use of limited 
power computation tools that are available. This paper confirms that a large control group is 
unnecessary and will improve the understanding of a broad group of public health 
practitioners.
In this paper we chose to represent intervention effect as the simple difference between 
means, because it directly measures the intervention effect most meaningful to public health 
practitioners, and is consistent with national, state and local goals and objectives. We 
acknowledge some controversy in the choice of intervention effect presented here, and 
suggest that this may be worthy of further consideration such as computing multiple 
definitions of intervention effect size for comparative purposes as for comparative 
effectiveness research studies using very small sample sizes [26].
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In this paper, although a similar mean intervention effect is found in simulated studies by 
control group size, examination of uncertainty in effect did vary slightly. Of several 
measures of uncertainty examined, most suggest that a small control group (30 and 60 
participants) is likely to provide a reasonable degree of certainty using the binomial 
distribution. Regardless of control group size, the size of estimated intervention effects was 
equivalent. In addition, imprecision is approximately 1% using a binomial distribution, mean 
power of studies is nearly 100% and variability of observed intervention effect from the 
actual estimate (intervention effect found in actual study population) or MSE is low 
(approximately 1–2%). The average power in detecting a true difference was high regardless 
of control group sizes because of the relatively large intervention effect (14%) in the actual 
study and large size of the intervention group, which was the same size in all simulated 
studies. Again, the study design and representativeness of WIC-enrolled children in Chicago 
may also explain similar intervention effect sizes regardless of control group size.
Although assessment of a small versus larger control groups is limited because ICC was not 
accounted for in total variance in simulated studies as mentioned previously, the ICC at 
baseline was very low (3%) and adjusted estimates of precision including the ICC in 
baseline vaccination coverage levels found similar results as unadjusted estimates. 
Moreover, ICC is a relatively constant value regardless of control group size, and 
comparisons are made of relative and not absolute measures of uncertainty (precision, power 
and MSE). Overall, findings of uncertainty (excluding ICC) seem to provide a reasonable 
assessment of random error, because nearly all of variability in the actual group-randomized 
trial is between groups and low intragroup correlation is likely acceptable in public health 
practice for communities in which a large intervention effect has been found. Furthermore, a 
recent literature review of ICCs in estimating sample size and power in community trials 
indicate that ICCs vary widely, depend on the outcome measure, depend on adjustment of 
covariables and should be considered on a study-by-study basis [27–29]. For example, 
estimation of ICC from 23 variables in the Minnesota Heart Health program ranged from 
0.002 to 0.012 [27]. Moreover, immunization effectiveness studies in WIC sites from which 
the Community Guide has made recommendations on improving vaccination coverage 
excluded ICCs because they were small. These small ICCs and the small ICC in the present 
study suggest that careful interpretation of small ICCs from group-randomized controlled 
community trials relative to intervention effect seems warranted.
As mentioned, to date there are considerable limits to the available evidence base for public 
health practice [7,11]. Published community effectiveness studies typically have large 
sample sizes [11,30,31]. However, sample sizes in community-based research typically are 
small [32,33], and intervention effectiveness seems often undeterminable because of sample 
size. These small studies are generally not published in the literature (publication bias). In 
fact when the medical and social science literatures are searched using key words of ‘small 
community studies or trials,’ case studies in communities are mostly found [11,30,31,34]. If 
a small sample size is mentioned, it only refers to the number of groups examined and not to 
the number of participants in a group [34–36]. In the present analysis, we examined if there 
are circumstances in which a small control group is as reliable in assessing an intervention 
effect and found that a small sample size for the control group is as reliable as larger sample 
sizes. This type of effectiveness study may provide adequate internal validity of the study at 
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an affordable cost. Although an immunization example has been presented, future research 
with the same or different data sources could include other interventions in which the 
outcome measure is a mean or count, both control and intervention groups are small or 
balanced and the intervention effect is expected to be smaller or larger than found in the 
present study.
The present study could have implications for community-based, effectiveness research, 
particularly for racial and ethnic minority subpopulations in local communities. If a minority 
group has small numbers in a community, the control group instead could have been a small 
population group. Typically, minority populations are oversampled to ensure an adequate 
number is included in the study [37], which comes at a financial cost that may not be 
available for all communities and local public health agencies because of competing health 
or other service priorities. This method may improve evidence-based public health and 
practice-based evidence in communities by now including valid and reliable evidence 
applicable to minority populations at a more affordable price.
Currently, public health practitioners are likely concerned about results from small 
community studies [38]. We found a large probability of detecting elevated intervention 
effects among simulated studies by control group size (i.e., 85–99% of studies), varying 
from the smallest to largest control group size based on the empirical distribution. If the 
empirical distribution instead of the binomial distribution is used to account for uncertainty, 
public health practitioners may want then to weigh the risk of having an 85 versus 99% 
likelihood of finding an intervention effect with a small control group versus a large control 
group against the cost and public health significance of findings. Guidance on public health 
situations in which small studies provide less or equal certainty as large studies and are cost-
effective may help public health agencies and community organizations contribute more to 
the scientific evidence for public health practice and stimulate a growing literature on 
practice-based evidence that improves population health. Consideration of public health 
significance of studies could include community needs for more or less certainty in 
intervention effect, available funds for study, scope of implementation of findings, 
immediate use of findings, target population for intervention and consequences of being 
wrong.
This concept of contextual significance has been applied to findings from small clinical 
trials. For instance, recommendations from a 2001 Institute of Medicine report on the value 
of small clinical trials indicate that properly designed trials with small samples can 
contribute to efficacy in particular situations such as rare diseases, unique study populations, 
individually tailored therapies, isolated environments, emergency situations, a public health 
emergency and restricted resources with an important need [39]. These recommendations 
illustrate which situations clinical significance is considered in accepting results from small 
trials. Public health practitioners too could consider the public health significance of 
findings for communities in deciding to apply results from effectiveness studies with a small 
sample size.
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The primary implication of our findings is that an immunization effectiveness study using a 
group-RCT with a small control group seems to provide an equivalent estimated intervention 
effect as does a study with a larger control group, particularly for public health practice in 
which programs could be implemented and estimated to have a substantial impact within the 
first year of implementation. This is an example of a study with a sizable intervention effect 
(14%) and small (near zero) background changes in vaccination in the community. Future 
studies that seek to assess the effectiveness of immunization interventions with a similar 
study design may consider using a smaller, unbalanced control group to detect changes in 
mean proportions. This study design may also be used to measure effects from other 
community interventions. In addition, the concept of public health significance and guidance 
for application of this significance need further exploration.
Future perspective
To improve public health in the USA, evidence-based recommendations of the CPSTF have 
and will continue to play an integral role in effective public health practice in communities. 
The Patient Protection and Affordable Care Act requires the CPSTF to report annually on 
gaps in topics and populations found in the scientific evidence for community preventive 
interventions. To close these gaps, public health and community health practitioners are 
important sources for contributing to the relevant evidence base for effective practice in 
communities. Knowledge of when smaller sample sizes can reliably identify effective 
interventions is likely to enable practitioners to initiate and conduct effectiveness research to 
improve community health.
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• Findings from this paper that sometimes smaller than usual samples may 
provide the same reliability of intervention effect size as larger samples may 
encourage public health and community health practitioners to conduct 
effectiveness research and strengthen the evidence base for the Guide to 
Community Preventive Services (Community Guide), which seeks to improve 
evidence-based public health in the USA.
• To show the value of a small control group in a group-randomized trial, we 
performed computerized simulations of hypothetical immunization 
effectiveness studies using data from an actual study population and found 
results likely to interest practitioners in initiating effectiveness research in 
their communities.
• In 2000 simulations of hypothetical group-randomized controlled trials 
examining immunization effectiveness by comparing either a small (30 and 
60 children) control group or larger (100 and 200) control groups with the 
same large intervention group of 200 children, an equivalent estimated 
intervention effect was found for trials regardless of control group size when 
there is a sizable intervention effect (14%) in 1 year and small (near zero) 
background changes in vaccination in the community.
• Although the intraclass (ICC) or intragroup correlation was excluded from 
our analyses because baseline ICC was small (3% of total variance) relative to 
total variance in the actual study, our reliability findings of intervention 
effects provide a reasonable assessment of random error because comparisons 
between trials with small and larger control groups are relative and not 
absolute measures of uncertainty and unadjusted and adjusted ICC precisions 
are similar.
• Furthermore, low intragroup correlations are likely acceptable in public health 
practice in communities when there is a large intervention effect and 
consideration of public health significance could complement decision 
making as has been discussed by the Institute of Medicine in a report on the 
issues and challenges of small clinical trials.
• Potential gains from a small control group compared with no control group 
are improved internal validity at an affordable price for practitioners.
• Although we may not generalize to all studies, results may be relevant to 
similarly well-designed and executed effectiveness studies measuring a 
difference between mean proportions and those seeking to include minority 
populations.
• As the role of the Community Preventive Services Task Force matures in 
generating the evidence base for public health practice for the nation, relevant 
effectiveness research initiated and conducted by public health and 
community health practitioners will be increasingly important as a critical 
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resource for identifying what works in improving population-level health in 
communities.
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Figure 1. Descriptive statistics of intervention effects from 2000 simulated studies with a control 
group of 30 children and an intervention group of 200 children
EFFDIFF: Intervention effect; n: Number of simulated studies; Mu: Mean; StDev: Standard 
deviation.
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Figure 2. Descriptive statistics of intervention effects from 2000 simulated studies with a control 
group of 60 children and an intervention group of 200 children
EFFDIFF: Intervention effect; n: Number of simulated studies; Mu: Mean; StDev: Standard 
deviation.
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Figure 3. Descriptive statistics of intervention effects from 2000 simulated studies with a control 
group of 100 children and an intervention group of 200 children
EFFDIFF: Intervention effect; n: Number of simulated studies; Mu: Mean; StDev: Standard 
deviation.
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Figure 4. Descriptive statistics of intervention effects from 2000 simulated studies with a control 
group of 200 children and an intervention group of 200 children
EFFDIFF: Intervention effect; n: Number of simulated studies; Mu: Mean; StDev: Standard 
deviation.
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Figure 5. Measures of uncertainty and power by sample size in control group in 2000 simulated 
studies
Precision is the 95% CI and mean power is average statistical power of simulated studies in 
detecting a difference using a two-sided type I error of 0.05.
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